ELEV Annual CFO
-$56.18 M
+$29.30 M+34.28%
31 December 2023
Summary:
As of January 23, 2025, ELEV annual cash flow from operations is -$56.18 million, with the most recent change of +$29.30 million (+34.28%) on December 31, 2023. During the last 3 years, it has fallen by -$43.88 million (-356.82%). ELEV annual CFO is now -356.82% below its all-time high of -$12.30 million, reached on December 31, 2020.ELEV Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELEV Quarterly CFO
-$8.38 M
-$177.00 K-2.16%
30 September 2024
Summary:
As of January 23, 2025, ELEV quarterly cash flow from operations is -$8.38 million, with the most recent change of -$177.00 thousand (-2.16%) on September 30, 2024. Over the past year, it has increased by +$1.19 million (+12.46%). ELEV quarterly CFO is now -426.18% below its all-time high of -$1.59 million, reached on March 31, 2020.ELEV Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELEV TTM CFO
-$38.34 M
+$4.97 M+11.48%
30 September 2024
Summary:
As of January 23, 2025, ELEV TTM cash flow from operations is -$38.34 million, with the most recent change of +$4.97 million (+11.48%) on September 30, 2024. Over the past year, it has increased by +$10.58 million (+21.63%). ELEV TTM CFO is now -2306.97% below its all-time high of -$1.59 million, reached on March 31, 2020.ELEV TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELEV Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +34.3% | +12.5% | +21.6% |
| 3 y3 years | -356.8% | +53.0% | +55.1% |
| 5 y5 years | - | +53.0% | +55.1% |
ELEV Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -86.2% | +34.3% | -2.2% | +81.0% | -27.1% | +58.6% |
| 5 y | 5-year | -356.8% | +34.3% | -426.2% | +81.0% | -2307.0% | +58.6% |
| alltime | all time | -356.8% | +34.3% | -426.2% | +81.0% | -2307.0% | +58.6% |
Elevation Oncology Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$8.38 M(+2.2%) | -$38.34 M(-11.5%) |
| June 2024 | - | -$8.21 M(-14.3%) | -$43.32 M(-11.5%) |
| Mar 2024 | - | -$9.57 M(-21.4%) | -$48.92 M(-12.9%) |
| Dec 2023 | -$56.18 M(-34.3%) | -$12.18 M(-8.8%) | -$56.18 M(-9.2%) |
| Sept 2023 | - | -$13.36 M(-3.3%) | -$61.85 M(-33.3%) |
| June 2023 | - | -$13.81 M(-17.9%) | -$92.67 M(+5.0%) |
| Mar 2023 | - | -$16.83 M(-5.7%) | -$88.29 M(+3.3%) |
| Dec 2022 | -$85.48 M | -$17.85 M(-59.6%) | -$85.48 M(+11.7%) |
| Sept 2022 | - | -$44.18 M(+368.7%) | -$76.55 M(+90.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | -$9.43 M(-32.8%) | -$40.27 M(+16.0%) |
| Mar 2022 | - | -$14.02 M(+57.3%) | -$34.71 M(+15.1%) |
| Dec 2021 | -$30.17 M(+145.3%) | -$8.91 M(+12.8%) | -$30.17 M(+22.5%) |
| Sept 2021 | - | -$7.90 M(+104.1%) | -$24.64 M(+14.8%) |
| June 2021 | - | -$3.87 M(-59.1%) | -$21.46 M(+6.3%) |
| Mar 2021 | - | -$9.48 M(+180.1%) | -$20.18 M(+64.1%) |
| Dec 2020 | -$12.30 M | -$3.38 M(-28.4%) | -$12.30 M(+37.9%) |
| Sept 2020 | - | -$4.73 M(+82.2%) | -$8.91 M(+112.9%) |
| June 2020 | - | -$2.60 M(+62.9%) | -$4.19 M(+162.9%) |
| Mar 2020 | - | -$1.59 M | -$1.59 M |
FAQ
- What is Elevation Oncology annual cash flow from operations?
- What is the all time high annual CFO for Elevation Oncology?
- What is Elevation Oncology annual CFO year-on-year change?
- What is Elevation Oncology quarterly cash flow from operations?
- What is the all time high quarterly CFO for Elevation Oncology?
- What is Elevation Oncology quarterly CFO year-on-year change?
- What is Elevation Oncology TTM cash flow from operations?
- What is the all time high TTM CFO for Elevation Oncology?
- What is Elevation Oncology TTM CFO year-on-year change?
What is Elevation Oncology annual cash flow from operations?
The current annual CFO of ELEV is -$56.18 M
What is the all time high annual CFO for Elevation Oncology?
Elevation Oncology all-time high annual cash flow from operations is -$12.30 M
What is Elevation Oncology annual CFO year-on-year change?
Over the past year, ELEV annual cash flow from operations has changed by +$29.30 M (+34.28%)
What is Elevation Oncology quarterly cash flow from operations?
The current quarterly CFO of ELEV is -$8.38 M
What is the all time high quarterly CFO for Elevation Oncology?
Elevation Oncology all-time high quarterly cash flow from operations is -$1.59 M
What is Elevation Oncology quarterly CFO year-on-year change?
Over the past year, ELEV quarterly cash flow from operations has changed by +$1.19 M (+12.46%)
What is Elevation Oncology TTM cash flow from operations?
The current TTM CFO of ELEV is -$38.34 M
What is the all time high TTM CFO for Elevation Oncology?
Elevation Oncology all-time high TTM cash flow from operations is -$1.59 M
What is Elevation Oncology TTM CFO year-on-year change?
Over the past year, ELEV TTM cash flow from operations has changed by +$10.58 M (+21.63%)